1152430-26-6 Usage
General Description
4-Boc-Amino-1-cyclopropanecarbonylpiperidine is a chemical compound with the molecular formula C16H24N2O3. It is a piperidine derivative with a Boc-protected amino group and a cyclopropane carbonyl group. 4-Boc-Amino-1-cyclopropanecarbonylpiperidine is often used in organic synthesis and medicinal chemistry as a building block for the synthesis of various pharmaceutical compounds. It has potential applications in the development of new drugs and bioactive molecules due to its unique structural features. The Boc-protecting group can be selectively removed under certain conditions, allowing for further functionalization of the amino group. Overall, 4-Boc-Amino-1-cyclopropanecarbonylpiperidine is an important chemical in the field of organic chemistry and drug discovery.
Check Digit Verification of cas no
The CAS Registry Mumber 1152430-26-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,5,2,4,3 and 0 respectively; the second part has 2 digits, 2 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1152430-26:
(9*1)+(8*1)+(7*5)+(6*2)+(5*4)+(4*3)+(3*0)+(2*2)+(1*6)=106
106 % 10 = 6
So 1152430-26-6 is a valid CAS Registry Number.
1152430-26-6Relevant articles and documents
Structure-activity relationships for a series of (Bis(4-fluorophenyl)methyl)sulfinylethyl-aminopiperidines and -piperidine amines at the dopamine transporter: Bioisosteric replacement of the piperazine improves metabolic stability
Giancola, JoLynn B.,Bonifazi, Alessandro,Cao, Jianjing,Ku, Therese,Haraczy, Alexandra J.,Lam, Jenny,Rais, Rana,Coggiano, Mark A.,Tanda, Gianluigi,Newman, Amy Hauck
, (2020/09/17)
Despite considerable efforts to develop medications to treat psychostimulant use disorders, none have proven effective, leaving an underserved patient population and unanswered questions as to what mechanism(s) of action should be targeted for developing
ATYPICAL INHIBITORS OF MONOAMINE TRANSPORTERS; METHOD OF MAKING; AND USE THEREOF
-
Paragraph 0115, (2019/05/30)
Disclosed herein are a series of modafinil analogue compounds that bind with moderate to high affinity to the dopamine (DA) transporter (DAT) and several analogues also having affinity for the serotonin (5-HT) transporter (SERT) and/or sigma-1 receptor. E
